47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | 0,1 | 30,3 |
EBITDA | 0,1 | 0,2 | 190,5 |
Short time liabilities | 0,5 | 1,7 | 215 |
Equity capital | -0,4 | -0,3 | 20,2 |
Operating profit (EBIT) | 0,1 | 0,2 | 149,2 |
Assets | 0,2 | 1,4 | 630,2 |
Net profit (loss) | 0,1 | 0,1 | 18,5 |
Cash | 0 | 0,4 | 870,4 |
Net income from sale | 3,7 | 3,3 | -11,1 |
Liabilities and provisions for liabilities | 0,6 | 1,7 | 206,4 |
Working assets | 0,2 | 1,3 | 572,5 |
Depreciation | 0 | 0 | -∞ |
% | % | p.p. | |
Profitability of capital | -17,1 | -25,3 | -8,2 |
Equity capital to total assets | -187 | -20,4 | 166,6 |
Gross profit margin | 1,7 | 2,5 | 0,8 |
EBITDA Margin | 1,7 | 5,6 | 3,9 |
Days | Days | Days | |
Short term commitment turnover cycle | 54 | 191 | 137 |
Current financial liquidity indicator | 0.34848594665527344 | 0.7668949365615845 | 0,5 |
Net dept to EBITDA | 1.0663529634475708 | -0.28258001804351807 | -1,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane